McKesson Return on Tangible Equity 2010-2023 | MCK

Current and historical return on tangible equity values for McKesson (MCK) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
McKesson Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $3.00B $-13.75B -22.03%
2023-09-30 $3.49B $-13.54B -25.38%
2023-06-30 $3.75B $-13.43B -27.88%
2023-03-31 $3.56B $-13.71B -26.77%
2022-12-31 $3.14B $-14.30B -23.81%
2022-09-30 $2.06B $-12.36B -16.16%
2022-06-30 $1.40B $-12.82B -11.07%
2022-03-31 $1.11B $-13.30B -8.91%
2021-12-31 $1.41B $-12.38B -11.55%
2021-09-30 $-4.81B $-11.95B 39.02%
2021-06-30 $-4.50B $-12.36B 41.18%
2021-03-31 $-4.54B $-12.20B 47.56%
2020-12-31 $-4.18B $-12.77B 50.43%
2020-09-30 $2.23B $-6.35B -33.19%
2020-06-30 $0.92B $-6.86B -13.80%
2020-03-31 $0.90B $-7.21B -14.50%
2019-12-31 $-0.92B $-6.44B 16.39%
2019-09-30 $-0.63B $-6.21B 12.08%
2019-06-30 $0.60B $-4.97B -11.90%
2019-03-31 $0.03B $-4.76B -0.67%
2018-12-31 $-0.32B $-5.05B 6.19%
2018-09-30 $0.12B $-5.22B -2.44%
2018-06-30 $-0.38B $-5.20B 8.13%
2018-03-31 $0.07B $-4.97B -1.49%
2017-12-31 $4.80B $-3.95B -120.18%
2017-09-30 $4.53B $-4.58B -98.65%
2017-06-30 $4.84B $-4.48B -114.30%
2017-03-31 $5.07B $-2.98B -117.69%
2016-12-31 $1.91B $-6.34B -42.39%
2016-09-30 $1.91B $-3.13B -49.23%
2016-06-30 $2.22B $-4.78B -53.55%
2016-03-31 $2.26B $-3.80B -55.51%
2015-12-31 $1.96B $-3.84B -44.41%
2015-09-30 $1.80B $-4.19B -38.93%
2015-06-30 $1.65B $-4.44B -36.76%
2015-03-31 $1.48B $-5.17B -33.62%
2014-12-31 $1.71B $-4.66B -40.65%
2014-09-30 $1.31B $-3.67B -41.68%
2014-06-30 $1.24B $-4.06B -53.08%
2014-03-31 $1.26B $-4.48B -79.52%
2013-12-31 $1.15B $-0.34B -132.49%
2013-09-30 $1.39B $-0.48B -213.16%
2013-06-30 $1.38B $-1.05B -450.53%
2013-03-31 $1.34B $-1.61B 1656.97%
2012-12-31 $1.60B $0.54B 323.72%
2012-09-30 $1.60B $0.89B 209.75%
2012-06-30 $1.50B $0.50B 175.45%
2012-03-31 $1.40B $0.05B 141.11%
2011-12-31 $1.30B $1.62B 97.90%
2011-09-30 $1.16B $1.25B 95.14%
2011-06-30 $1.19B $1.06B 74.46%
2011-03-31 $1.20B $1.40B 58.89%
2010-12-31 $1.13B $1.16B 44.34%
2010-09-30 $1.30B $2.77B 43.31%
2010-06-30 $1.27B $2.84B 43.20%
2010-03-31 $1.26B $3.41B 45.75%
2009-12-31 $1.20B $2.98B 49.66%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $68.967B $276.711B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00